GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
68 hedge funds and large institutions have $446M invested in GW Pharmaceuticals Plc American Depositary Shares in 2014 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 7 closing their positions.
600% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 7
175% more capital invested
Capital invested by funds: $162M → $446M (+$284M)
162% more funds holding
Funds holding: 26 → 68 (+42)
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
4% more call options, than puts
Call options by funds: $968K | Put options by funds: $927K
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$48.1M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$28M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$22.2M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$19.5M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$19.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$13.4M |
| 2 |
Millennium Management
New York
|
-$8.67M |
| 3 |
PC
Pier Capital
Stamford,
Connecticut
|
-$4.94M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$3.91M |
| 5 |
VM
VHCP Management
New York
|
-$3.27M |
GWPH Hedge Fund Activity: Q1 2014 in Review
68 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q1 2014, worth a combined $446M — up 175% from $162M a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new GWPH positions and 7 closed out — a net gain of 42 holders — while 8 added to existing stakes and 7 trimmed.
The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $48.1M. The largest seller was OrbiMed, cutting an estimated $13.4M.
- 68 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q1 2014, up from 26 in Q4 2013.
- Funds reported $446M of GW Pharmaceuticals Plc American Depositary Shares stock for Q1 2014, up 175% quarter-over-quarter.
- 49 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q1 2014 and 7 closed out, a net change of +42 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q1 2014 was Capital Research Global Investors, an estimated $48.1M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q1 2014 was OrbiMed, an estimated $13.4M sold.
Based on aggregated 13F filings for Q1 2014.